Nymox Pharmaceutical Corp Коэффициент "короткого" интереса

Что обозначает Коэффициент "короткого" интереса в Nymox Pharmaceutical Corp?

Коэффициент "короткого" интереса Nymox Pharmaceutical Corp является 29.14

Какое определение для Коэффициент "короткого" интереса?

Краткосрочный коэффициент - это количество проданных акций, которых нет в наличии, деленное на среднесуточный объем.

Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.

The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.

Что делает Nymox Pharmaceutical Corp?

nymox pharmaceutical corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. its lead drug candidate is fexapotide triflutate (nx-1207) that has completed phase iii clinical trials for the treatment of benign prostatic hyperplasia; and is in phase ii clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. the company also develops and markets nicalert and tobacalert test strips that use urine or saliva to detect use of tobacco products. in addition, it offers alzheimalert, a proprietary urine assay that aids physicians in the diagnosis of alzheimer's disease. the company operates in canada, the united states, europe, and internationally. nymox pharmaceutical corporation was founded in 1989 and is headquartered in nassau, bahamas.

Компании с коэффициент "короткого" интереса похож на Nymox Pharmaceutical Corp

  • DBV Technologies имеет Коэффициент "короткого" интереса из 27.73
  • BTB Real Estate Investment Trust имеет Коэффициент "короткого" интереса из 28.06
  • VirnetX Corp имеет Коэффициент "короткого" интереса из 28.35
  • Virnetx Corp имеет Коэффициент "короткого" интереса из 28.35
  • BSR Real Estate Investment Trust имеет Коэффициент "короткого" интереса из 28.95
  • ALX Oncology имеет Коэффициент "короткого" интереса из 29.05
  • Nymox Pharmaceutical Corp имеет Коэффициент "короткого" интереса из 29.14
  • Dream Finders Homes имеет Коэффициент "короткого" интереса из 29.24
  • Molson Coors Canada имеет Коэффициент "короткого" интереса из 29.29
  • ADC Therapeutics SA имеет Коэффициент "короткого" интереса из 29.34
  • Kaleido Biosciences Inc имеет Коэффициент "короткого" интереса из 29.34
  • Aphelion Capital имеет Коэффициент "короткого" интереса из 29.47
  • Citius Pharmaceuticals Inc имеет Коэффициент "короткого" интереса из 29.62